Duan et al. [76] examined the effects of BzBP (10−8 M) on acute myeloid leukaemia (AML) cells and found increased cell proliferation, glycolysis, pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4), and anticancer treatment desensitization. Here, PDK4 is linked to acute myeloid leukemia.